I 25 (Glyburide and metformin 1.25 mg / 250 mg)

Pill imprint I 25 has been identified as Glyburide and metformin 1.25 mg / 250 mg.

Glyburide/metformin is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. There is no proven risk in humans during pregnancy. Glyburide/metformin 1.25 mg / 250 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for I 25

Glyburide and metformin 1.25 mg / 250 mg I 25
Glyburide and metformin
Imprint:
I 25
Strength:
1.25 mg / 250 mg
Color:
Yellow
Size:
11.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Antidiabetic combinations
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Dr. Reddy’s Laboratories Inc.
National Drug Code (NDC):
55111-0695
Inactive Ingredients:
sodium starch glycolate type A potato
povidone
silicon dioxide
magnesium stearate
hypromellose
magnesium silicate
titanium dioxide
polyethylene glycol 6000
propylene glycol
ferric oxide yellow

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)